Description
Table S3. Duration and amount of HBV medications and interferons in patients who received them in the study period, as grouped according to the use of ACEIs or ARBs within 6Â months after the index date. (DOCX 17Â kb)
| Date made available | Apr 10 2018 |
|---|---|
| Publisher | Unknown Publisher |
Research output
- 1 Article
-
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
Ho, C. M., Lee, C. H., Lee, M. C., Zhang, J. F., Wang, J. Y., Hu, R. H. & Lee, P. H., Apr 10 2018, In: BMC Cancer. 18, 1, p. 401 401.Research output: Contribution to journal › Article › peer-review
30 Link opens in a new tab Citations (Scopus)
Cite this
- DataSetCite